Kidney Cancer Therapeutics Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
Kidney Cancer Therapeutics Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
Discover the latest insights into the booming Kidney Cancer Therapeutics Market. This report analyzes market size, growth trends (CAGR ), key players, and regional performance, offering valuable data for investors and industry professionals. Explore market drivers, restraints, and future projections for -.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Kidney cancer is cancer that begins in the kidneys. Your kidneys are two bean-shaped organs, each about the size of your fist. They're located behind your abdominal organs, with one kidney on each side of your spine. In adults, renal cell carcinoma is the most common type of kidney cancer.
This report aims to provide a comprehensive presentation of the global market for Kidney Cancer Therapeutics study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.
Global Kidney Cancer Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Kidney Cancer Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Surgery Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Kidney Cancer Therapeutics include Merck, Novartis, Bristol-Myers Squibb, Pfizer, Roche, Amgen, Aveo Pharmaceuticals, Bayer and Exelixis and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
The study provides the Kidney Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Segmental Outline:
Global Kidney Cancer Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Kidney Cancer Therapeutics Market Segment Percentages, by Type, 2021 (%)
Surgery
Immunotherapy
Targeted Therapy
Other
Global Kidney Cancer Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Kidney Cancer Therapeutics Market Segment Percentages, by Application, 2021 (%)
Renal Cell Carcinoma
Renal Pelvis Cancer
Other
Global Kidney Cancer Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Kidney Cancer Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Kidney Cancer Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Kidney Cancer Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Novartis
Bristol-Myers Squibb
Pfizer
Roche
Amgen
Aveo Pharmaceuticals
Bayer
Exelixis
Eisai
This Report Addresses:
– Market Intelligence enables effective decision-making
– Market estimates and forecasts from 2022 to 2028
– Growth opportunities and trend analysis
– Segment and regional revenue forecast for market evaluation
– Competitive strategy and analysis of market segments
– List of product innovations to stay on top.
– The impact of COVID-19 and how to survive in these fast-growing markets.
1 Introduction to Research & Analysis Reports
1.1 Kidney Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Kidney Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Kidney Cancer Therapeutics Overall Market Size
2.1 Global Kidney Cancer Therapeutics Market Size: 2021 VS 2028
2.2 Global Kidney Cancer Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Kidney Cancer Therapeutics Players in Global Market
3.2 Top Global Kidney Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Kidney Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Kidney Cancer Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Kidney Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Kidney Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Kidney Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Kidney Cancer Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Kidney Cancer Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Surgery
4.1.3 Immunotherapy
4.1.4 Targeted Therapy
4.1.5 Other
4.2 By Type - Global Kidney Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Kidney Cancer Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Kidney Cancer Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Kidney Cancer Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Kidney Cancer Therapeutics Market Size, 2021 & 2028
5.1.2 Renal Cell Carcinoma
5.1.3 Renal Pelvis Cancer
5.1.4 Other
5.2 By Application - Global Kidney Cancer Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Kidney Cancer Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Kidney Cancer Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Kidney Cancer Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Kidney Cancer Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Kidney Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Kidney Cancer Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Kidney Cancer Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Kidney Cancer Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Kidney Cancer Therapeutics Revenue, 2017-2028
6.3.2 US Kidney Cancer Therapeutics Market Size, 2017-2028
6.3.3 Canada Kidney Cancer Therapeutics Market Size, 2017-2028
6.3.4 Mexico Kidney Cancer Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Kidney Cancer Therapeutics Revenue, 2017-2028
6.4.2 Germany Kidney Cancer Therapeutics Market Size, 2017-2028
6.4.3 France Kidney Cancer Therapeutics Market Size, 2017-2028
6.4.4 U.K. Kidney Cancer Therapeutics Market Size, 2017-2028
6.4.5 Italy Kidney Cancer Therapeutics Market Size, 2017-2028
6.4.6 Russia Kidney Cancer Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Kidney Cancer Therapeutics Market Size, 2017-2028
6.4.8 Benelux Kidney Cancer Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Kidney Cancer Therapeutics Revenue, 2017-2028
6.5.2 China Kidney Cancer Therapeutics Market Size, 2017-2028
6.5.3 Japan Kidney Cancer Therapeutics Market Size, 2017-2028
6.5.4 South Korea Kidney Cancer Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Kidney Cancer Therapeutics Market Size, 2017-2028
6.5.6 India Kidney Cancer Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Kidney Cancer Therapeutics Revenue, 2017-2028
6.6.2 Brazil Kidney Cancer Therapeutics Market Size, 2017-2028
6.6.3 Argentina Kidney Cancer Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Kidney Cancer Therapeutics Revenue, 2017-2028
6.7.2 Turkey Kidney Cancer Therapeutics Market Size, 2017-2028
6.7.3 Israel Kidney Cancer Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Kidney Cancer Therapeutics Market Size, 2017-2028
6.7.5 UAE Kidney Cancer Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Kidney Cancer Therapeutics Major Product Offerings
7.1.4 Merck Kidney Cancer Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Merck Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Kidney Cancer Therapeutics Major Product Offerings
7.2.4 Novartis Kidney Cancer Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Novartis Key News
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Corporate Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Kidney Cancer Therapeutics Major Product Offerings
7.3.4 Bristol-Myers Squibb Kidney Cancer Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Bristol-Myers Squibb Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Kidney Cancer Therapeutics Major Product Offerings
7.4.4 Pfizer Kidney Cancer Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Pfizer Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Kidney Cancer Therapeutics Major Product Offerings
7.5.4 Roche Kidney Cancer Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Roche Key News
7.6 Amgen
7.6.1 Amgen Corporate Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Kidney Cancer Therapeutics Major Product Offerings
7.6.4 Amgen Kidney Cancer Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Amgen Key News
7.7 Aveo Pharmaceuticals
7.7.1 Aveo Pharmaceuticals Corporate Summary
7.7.2 Aveo Pharmaceuticals Business Overview
7.7.3 Aveo Pharmaceuticals Kidney Cancer Therapeutics Major Product Offerings
7.7.4 Aveo Pharmaceuticals Kidney Cancer Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Aveo Pharmaceuticals Key News
7.8 Bayer
7.8.1 Bayer Corporate Summary
7.8.2 Bayer Business Overview
7.8.3 Bayer Kidney Cancer Therapeutics Major Product Offerings
7.8.4 Bayer Kidney Cancer Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Bayer Key News
7.9 Exelixis
7.9.1 Exelixis Corporate Summary
7.9.2 Exelixis Business Overview
7.9.3 Exelixis Kidney Cancer Therapeutics Major Product Offerings
7.9.4 Exelixis Kidney Cancer Therapeutics Revenue in Global Market (2017-2022)
7.9.5 Exelixis Key News
7.10 Eisai
7.10.1 Eisai Corporate Summary
7.10.2 Eisai Business Overview
7.10.3 Eisai Kidney Cancer Therapeutics Major Product Offerings
7.10.4 Eisai Kidney Cancer Therapeutics Revenue in Global Market (2017-2022)
7.10.5 Eisai Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Kidney Cancer Therapeutics Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|